Clinical characteristics and treatment of hepatic portal venous gas: case series and literature review
Executive Summary
Hepatic portal venous gas (HPVG) is a critical radiological sign characterized by abnormal gas accumulation in the portal vein and its intrahepatic branches. Historically associated with a 75% mortality rate and regarded as a mandatory indication for surgery, HPVG management has evolved significantly due to advancements in computed tomography (CT). Recent data indicates that HPVG is a marker of serious underlying disease but does not universally require surgical intervention.
In a retrospective study of 21 patients, the overall in-hospital mortality rate was 23.8%, with bowel necrosis identified as the primary driver of fatal outcomes. While surgical and conservative treatments showed similar survival rates (approximately 75–77%), the decision to operate is increasingly guided by specific clinical predictors. Key indicators for surgical necessity include low platelet counts, elevated neutrophil levels, and the presence of hypertension or peritonitis. This document synthesizes clinical characteristics, etiologies, and treatment outcomes to provide a reference for risk stratification and management strategies.
Overview of HPVG Pathophysiology
HPVG is a rare radiological finding occurring when gas from the intestinal lumen or gas-producing bacteria enters the portal venous circulation. Four primary mechanisms facilitate this entry:
Intestinal Ischemia and Necrosis: Cell death in the intestinal wall releases gas directly into the system.
Bacterial Infection: Gas-producing organisms (e.g., Clostridium perfringens, Escherichia coli) generate significant gas volumes within the intestine.
Mechanical Injury: Abdominal surgery or trauma can damage vessel walls or the intestinal mucosa, providing a direct pathway for gas entry.
Pressure and Permeability: Increased intraluminal pressure, mucosal disruption, or inflammatory responses increase vascular permeability, allowing gas to pass into the portal venous system.
Clinical Characteristics and Laboratory Findings
Patients presenting with HPVG typically exhibit systemic inflammatory responses and vascular damage markers. The following table outlines the common laboratory deviations observed in clinical cases:
Etiologies and Comorbidities
The occurrence of HPVG is frequently tied to gastrointestinal crises and chronic vascular conditions.
Primary Etiologies
Peritonitis: Present in 52.4% of cases.
Post-Abdominal Surgery: Found in 47.6% of cases.
Intestinal Necrosis: Observed in 33.3% of cases.
Gastrointestinal Bleeding: Present in 28.6% of cases.
Other Causes: Intestinal obstruction (14.3%), gastrointestinal tumors (14.3%), and abdominal infections (9.5%).
Prevalent Comorbidities
Chronic conditions contribute to vascular fragility and inflammatory states, increasing HPVG risk:
Hypertension: 52.4%
Peritonitis: 52.4%
Coronary Heart Disease: 23.8%
Diabetes and Cerebrovascular Disease: 19.0% each.
Predictors for Surgical Intervention
The study identified specific markers that significantly correlate with the likelihood of requiring surgical management. Decisions are often based on the severity of underlying conditions rather than the presence of gas alone.
Note on Clinical Signs: Abdominal pain that is not relievable by medication and the presence of colic are also strong indicators for surgical consideration. Conversely, relief of pain through conservative treatment often suggests a favorable non-surgical prognosis.
Radiological Manifestations and Imaging Analysis
CT imaging is the gold standard for diagnosing HPVG. Gas typically presents in a branching pattern, often extending to the subcapsular region of the liver (within 2 cm of the liver capsule).
Distribution Patterns
The study identified nine distinct radiological manifestations categorized by gas extent:
Extensive Gas: Presence throughout the entire portal venous system, often occupying large areas in two or more hepatic segments.
Segmental Gas: Presence in more than two segments, but occupying smaller relative areas.
Minimal Gas: Located within a single segment or strictly within 2 cm of the liver capsule.
Clinical Correlation
Bowel Necrosis Correlation: Extensive and widespread gas distribution is closely associated with intestinal necrosis. 80% of fatal cases presented with ischemic bowel necrosis and widespread gas accumulation.
Mesenteric Involvement: The co-occurrence of mesenteric venous gas often indicates compromised intestinal wall integrity and is frequently seen in patients with intestinal bleeding and necrosis.
Treatment Outcomes and Prognosis
Modern management strategies have shifted toward personalized care, balancing surgical necessity against conservative viability.
Surgical Outcomes: Of patients undergoing surgery, the survival rate was 75%. Procedures included small intestine resection, hemicolectomy, and hemostasis.
Conservative Outcomes: Of patients receiving conservative treatment, 76.9% survived. This group typically included those without bowel necrosis or those responding well to initial medical management.
Mortality: The overall mortality rate was 23.8%. Fatalities were predominantly linked to:
Ischemic bowel necrosis (found in 80% of deceased patients).
End-stage malignancies.
Severe infections and multi-organ failure.
Conclusion
HPVG remains a marker of high-acuity illness, but it is no longer an absolute indicator for emergency surgery. Prognosis is generally favorable if effective treatment is administered before extensive bowel necrosis or severe sepsis occurs. Clinical management should be guided by a comprehensive assessment of platelet counts, neutrophil levels, and the presence of hypertension or peritonitis. Future management should focus on evidence-based algorithms that integrate these clinical predictors with imaging patterns to optimize patient selection for surgery versus conservative care.
